A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer

Xiaodan Lyu(China Pharmaceutical University), Li Sun(China Pharmaceutical University)
Cancers
October 20, 2023
Cited by 21


Related Papers